Raija R.
- Country
- Finland
- Department
- Department of Oncology
Research Overview
Data & Insights
Has run more than one trial at 20 of 116 partner sites.
Specializations
Colorectal Cancer Genetics
The investigator specializes in treating colorectal cancer patients with specific genetic mutations, particularly focusing on cases involving BRAF V600E mutations and KRAS G12C mutations in advanced stages of the disease.
- BRAF-mutant metastatic colorectal cancer
- KRAS mutation analysis
- Genetic profiling in colorectal cancer
Their research encompasses targeted therapeutic approaches for genetically characterized colorectal cancers.
Targeted Therapy Development
The investigator works with novel therapeutic combinations including targeted agents like encorafenib and cetuximab, as well as adagrasib-based combination treatments for specific genetic subtypes of colorectal cancer.
- Combination therapy strategies
- Novel drug development
- Personalized treatment approaches
Their work focuses on developing effective targeted treatment strategies for advanced colorectal cancer.
Advanced Treatment Protocols
The investigator evaluates second-line treatment options and compares various therapeutic combinations including standard chemotherapy protocols such as FOLFIRI and mFOLFOX6 with targeted approaches.
- Second-line therapy optimization
- Treatment sequence evaluation
- Comparative treatment efficacy
Their expertise extends to determining optimal treatment sequences for advanced colorectal cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.